Arbutus Biopharma Corp
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
ABUS | US
Overview
Corporate Details
- ISIN(s):
- CA03879J1003 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 701 VETERANS CIRCLE, 18974 WARMINSTER
- Website:
- https://www.arbutusbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company focused on virology, with a primary mission to develop a functional cure for chronic hepatitis B virus (HBV) infection. The company's strategy centers on developing combination drug regimens that attack the virus through multiple, complementary mechanisms. This multi-pronged approach aims to suppress viral DNA replication, reduce viral antigens (specifically HBsAg), and boost the host's immune response. Its innovative virology portfolio is led by imdusiran, an RNAi therapeutic being investigated as a cornerstone therapy in its HBV clinical studies. Arbutus leverages a team with deep scientific and commercial expertise to advance its pipeline for conditions with significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Arbutus Biopharma Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Arbutus Biopharma Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Arbutus Biopharma Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
